Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 3Withdrawn 2Terminated 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Lung Neoplasms 6Colorectal Neoplasms 6Stomach Neoplasms 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Hematologic Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Rectal Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3COVID-19 3Uterine Cervical Neoplasms 2Smoking 2Sarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Head and Neck Carcinoma 2Glioblastoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Xerostomia 1Urologic Neoplasms 1Urologic Diseases 1

Interventions

Temozolomide 41Radiotherapy 19Radiation 12Nivolumab 10pembrolizumab 8Magnetic Resonance Spectroscopy 8Bevacizumab 7Specimen Handling 6poly ICLC 4atezolizumab 4Lomustine 4Ipilimumab 4Surgical Procedures, Operative 3Photons 3Immunoglobulin G 3Disulfides 3Cyclophosphamide 3veliparib 2sargramostim 2rocakinogene sifuplasmid 2olaparib 2niraparib 2Transurethral Resection of Bladder 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2OKN 007 2Mycophenolic Acid 2Metformin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Glioblastoma × Standard of Care × Clear all
NCT04485949 2026-02-10

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Imvax

Phase 2 Active not recruiting
93 enrolled
CNS

Glioblastoma

NCT03395587 2024-12-02

GlioVax

Heinrich-Heine University, Duesseldorf

Phase 2 Active not recruiting
136 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡